Predictive Biomarkers for Precision Management of Pre-cancerous Cervical Neoplasia | MicrobiomeTrials← Back to trialsNCT07895641
Predictive Biomarkers for Precision Management of Pre-cancerous Cervical Neoplasia
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-09-19Est. Completion: 2027-06
Enrollment target: 199 participants Locations- Skåne University hospital, Lund, Sweden
Other microbiome trials you might be interested in
HSIL, High Grade Squamous Intraepithelial LesionCIN 2HPV (Human Papillomavirus)-AssociatedPhotodynamic Therapy (PDT)
This study evaluates the efficacy and safety of ALA-PDT versus LEEP in treating cervical HSIL/CIN2, aiming to demonstrat…
Hangzhou, ChinaEst. completion Dec 2027
Vulvar HSILHPV
Problem description:
Yearly, approximately 45000 women develop vulvar cancer worldwide. It is estimated that about 30% …
Rotterdam, NetherlandsEst. completion Dec 1, 2028